The VIBac 2022, a two-day conference and exhibition, kicked off at the COEX in southern Seoul on Monday, featuring Korean and foreign businesses related to the fields of virus and bacteria.Visitors to the event can access technologies in various areas, including diagnostics, biopharmaceuticals, micr
Celltrion received approval from the Polish Pharmaceutical and Medical Equipment Registration Office (URPL) on Monday for the phase 3 clinical trial (IND) of its Actemra biosimilar, "CT-P47," which treats rheumatoid arthritis treatment.Celltrion won the investigational new drug (IND) approval two mo
Hanmi Pharm released the second-quarter earnings report on Monday, earlier than expected, to refute an analyst report’s prediction of the drugmaker’s operating profit.In a regulatory filing on Monday, Hanmi announced that it recorded 316.5 billion won ($240.3 million) in sales, 29.6 billion won oper
After the Yoon Suk-yeol administration decided to make Covid-19 patients shoulder part of their treatment costs, a civic group harshly criticized the government, claiming its “scientific quarantine” is the “neglect of state’s responsibility.”The People's Solidarity for Participatory Democracy stress
CanariaBioM, a parent company of CanariaBio, signed a contract on Friday to take over Sejong Medical by acquiring a 100 percent share of the latter’s equity jointly with foreign financial investors.Through this acquisition, CanariaBioM will secure Sejong Medical’s medical device business and new dru
Technology transfers concerning new drug candidates made by Korean biopharmaceutical companies this year fell from a year ago.The license-out deals of Korean biopharmaceutical companies grew from 10.14 trillion won ($7.7 billion) in 2020 to 11.44 trillion won last year. The number of contracts also
The Ministry of Food and Drug Safety has suspended importing three Viatris Korea’s eye drop products for one through Aug. 14.The suspension of import business was due to the company’s failure to report the changes in the manufacturing client after the merger of the Upjohn division of Pfizer and Myla
The American Society of Clinical Oncology recently (ASCO) issued a “rapid recommendation” to use Kimmtrak (ingredient: tebentafusp) to treat uveal melanoma.Kimmtrak won FDA approval early this year as the first uveal melanoma treatment.With the latest ASCO’s recommendation, Kimmtrak became the stand
One in five students in elementary, middle, and high schools in Seoul were obese, and 30 percent of them were overweight in 2021, a government report showed.Rep. Shin Hyun-young of the Democratic Party released the Seoul Metropolitan Office of Education’s report on student health examination data be
HLB Therapeutics said Monday that it would simultaneously start clinical trials for neuroparalytic keratitis treatment in the U.S. and Europe, signing related contracts with a global contract research organization (CRO).Eye disease drugs usually require two repetitive clinical outcomes. However, HLB
Next&Bio and Korea Institute of Science and Technology (KIST)’s European Research Institute have signed a joint research agreement to register guidelines for the “OECD adverse outcome pathway (AOP) verification act” to replace animal testing with organoids.Under the accord, the institute will regist
Korean scientists have developed a multiple genetic detection platform that can precisely diagnose gastric cancer.The Korea Research Institute of Bioscience and Biotechnology (KRIBB) said Monday that its researchers developed a diagnostic platform that detects genetic markers within the blood with h
New Korean pharmaceutical companies are racing to develop botulinum toxin (BTX) to sell them in the U.S. and Europe instead of the saturated Korean market, industry officials said. Such companies include BioPlus, CKD Bio, Jetema, EuBiologics, and ATGC.On Thursday, BioPlus announced a 2.3 billion won
The government said Friday that it was not considering additional quarantine measures even after confirming the first case of BA.2.75, dubbed "Centaurus," the most contagious Omicron subvariant with greater immune-avoiding properties than BA.5.On Thursday, Korea confirmed the first BA.2.75 case from
Kangstem Biotech said Friday it reapplied for a phase 1/2a IND of Furestem-OA Kit Inj. for osteoarthritis treatment to the Ministry of Food and Drug Safety.The company reapplied for a phase 1/2a clinical IND about a month after it voluntarily withdrew its original investigational new drug applicatio
Severance Hospital has introduced an early recovery program for people who receive an artificial knee joint surgery by reducing their pains and shortening the recovery period, the hospital said Friday.Doctors consider artificial knee joint surgery for severe degenerative knee arthritis patients. The
Japanese pharmaceutical companies’ Korean offshoots recorded low growth in 2021, according to their audit reports.The audit reports showed that the combined sales of the nine Japanese drugmakers’ Korean offshoots stood at 1.44 trillion won ($1 billion) last year, marking an increase of a mere 1.4 pe
GC Wellbeing said on Friday that it signed a technology transfer contract with Japan's Healthy Navi for its functional raw material Green Cera-F, a honey suckle bud extract.Green Cera-F is a raw material that has been recognized by the Ministry of Food and Drug Safety for its functionality that can
The government is wielding excessive power to lower drug prices without recognizing the values of innovative medicines, an expert said.Kim Sung-ju, an expert advisor for Lee & Ko’s Healthcare Practice Group, published an article in the Korea Pharmaceutical and Bio-Pharma Manufacturers Association’s
Bayer Korea said it would continue marketing Nebido, its long-acting injectable for males with testosterone deficiency, in the country, although its headquarters handed over the drug’s global rights to Grünenthal, a German pharmaceutical company.Grünenthal has picked up the global rights for the dru